Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
IMMUNE SYSTEM INDUCTION OF NERVE GROWTH FACTOR IN AN ANIMAL MODEL OF MULTIPLE SCLEROSIS: IMPLICATIONS IN RE-MYELINATION AND MYELIN REPAIR.
Acid-Sensing Ion Channels Contribute to Neurotoxicity.
Severe demyelination but no astrocytopathy in clinically definite neuromyelitis optica with anti-myelin-oligodendrocyte glycoprotein antibody.
Active Cognitive Reserve Influences the Regional Atrophy to Cognition Link in Multiple Sclerosis.
P300 wave changes in patients with multiple sclerosis.
Protein kinase C gamma (PKCγ) as a novel marker to assess the functional status of the corticospinal tract in experimental autoimmune encephalomyelitis (EAE).
Role of sphingosine 1-phosphate receptors, sphingosine kinases and sphingosine in cancer and inflammation.
Oral therapy approved for multiple sclerosis.
Natalizumab SC Similar to IV Every 4 Weeks for MS
Thymosin beta 4 up-regulates miR-200a expression and induces differentiation and survival of rat brain progenitor cells.
Intractable cough as characteristic symptom of neuromyelitis optica and neuromyelitis optica spectrum disorder.
[Oral disease-modifying agents in relapsing-remitting multiple sclerosis].
Nutritional factors and aging in demyelinating diseases.
Tear analysis as a tool to detect oligoclonal bands in radiologically isolated syndrome.
Full-Length and Fragmented Netrin-1 in Multiple Sclerosis Plaques Are Inhibitors of Oligodendrocyte Precursor Cell Migration.
Functional limitations in functional somatic syndromes and well-defined medical diseases. Results from the general population cohort LifeLines.
Double Roles of Macrophages in Human Neuroimmune Diseases and Their Animal Models.
Current symptomatology in multiple sclerosis and neuromyelitis optica.
Grey matter damage in multiple sclerosis: A pathology perspective.
Case centered analysis of Optic Neuritis following vaccines.
[Retrovirus superantigen hypothesis of multiple sclerosis.]
[Proportion and significance of CD1d(hi)CD5(+)CD19(+) regulatory B cell in peripheral blood of patients with neuromyelitis optica].
Negative work events and accommodations in employed multiple sclerosis patients.
Hyaluronidase and Hyaluronan Oligosaccharides Promote Neurological Recovery after Intraventricular Hemorrhage.
Comparing neuromyelitis optica and multiple sclerosis severity: is there a difference?
Pages
« first
‹ previous
…
598
599
600
601
602
603
604
605
606
…
next ›
last »